Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2023 |
| Outros Autores: | , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Brazilian Journal of Health Review |
| Texto Completo: | https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57214 |
Resumo: | Cutaneous leishmaniasis (CL) is not a life-threatening condition, the treatment of which can cause serious adverse effects and sometimes lead to death. In this study, we report a case of success in the treatment of LC of a 2.5 cm lesion located in the neck region of a 22-year-old man treated with intralesional meglumine antiomoniate (IL-MA) without adverse effects and without recurrence or complications after 18 months of follow-up. The results suggest that the treatment of CL lesions with IL-MA is simple, efficient and safe. |
| id |
BJRH-0_90209a75b3416e73b0c38aa822ce120e |
|---|---|
| oai_identifier_str |
oai:ojs2.ojs.brazilianjournals.com.br:article/57214 |
| network_acronym_str |
BJRH-0 |
| network_name_str |
Brazilian Journal of Health Review |
| repository_id_str |
|
| spelling |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case reportLeishmaniaglucantimeneglected diseaseCutaneous leishmaniasis (CL) is not a life-threatening condition, the treatment of which can cause serious adverse effects and sometimes lead to death. In this study, we report a case of success in the treatment of LC of a 2.5 cm lesion located in the neck region of a 22-year-old man treated with intralesional meglumine antiomoniate (IL-MA) without adverse effects and without recurrence or complications after 18 months of follow-up. The results suggest that the treatment of CL lesions with IL-MA is simple, efficient and safe.Brazilian Journals Publicações de Periódicos e Editora Ltda.2023-02-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/5721410.34119/bjhrv6n1-259Brazilian Journal of Health Review; Vol. 6 No. 1 (2023); 3323-3328Brazilian Journal of Health Review; Vol. 6 Núm. 1 (2023); 3323-3328Brazilian Journal of Health Review; v. 6 n. 1 (2023); 3323-33282595-6825reponame:Brazilian Journal of Health Reviewinstname:Federação das Indústrias do Estado do Paraná (FIEP)instacron:BJRHenghttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57214/41892de Souza, Marcos VilelaCherem, Josédos Santos Júnior, Gilson ArgoloCésar, Antônia Amanda da SilvaNarciso, Thiago PasquaAlvarenga, Ingrid MarcianoBarçante, Thales AugustoBarçante , Joziana Muniz de Paivainfo:eu-repo/semantics/openAccess2023-02-15T18:18:04Zoai:ojs2.ojs.brazilianjournals.com.br:article/57214Revistahttp://www.brazilianjournals.com/index.php/BJHR/indexPRIhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/oai|| brazilianjhr@gmail.com2595-68252595-6825opendoar:2023-02-15T18:18:04Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP)false |
| dc.title.none.fl_str_mv |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| title |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| spellingShingle |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report de Souza, Marcos Vilela Leishmania glucantime neglected disease |
| title_short |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| title_full |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| title_fullStr |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| title_full_unstemmed |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| title_sort |
Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| author |
de Souza, Marcos Vilela |
| author_facet |
de Souza, Marcos Vilela Cherem, José dos Santos Júnior, Gilson Argolo César, Antônia Amanda da Silva Narciso, Thiago Pasqua Alvarenga, Ingrid Marciano Barçante, Thales Augusto Barçante , Joziana Muniz de Paiva |
| author_role |
author |
| author2 |
Cherem, José dos Santos Júnior, Gilson Argolo César, Antônia Amanda da Silva Narciso, Thiago Pasqua Alvarenga, Ingrid Marciano Barçante, Thales Augusto Barçante , Joziana Muniz de Paiva |
| author2_role |
author author author author author author author |
| dc.contributor.author.fl_str_mv |
de Souza, Marcos Vilela Cherem, José dos Santos Júnior, Gilson Argolo César, Antônia Amanda da Silva Narciso, Thiago Pasqua Alvarenga, Ingrid Marciano Barçante, Thales Augusto Barçante , Joziana Muniz de Paiva |
| dc.subject.por.fl_str_mv |
Leishmania glucantime neglected disease |
| topic |
Leishmania glucantime neglected disease |
| description |
Cutaneous leishmaniasis (CL) is not a life-threatening condition, the treatment of which can cause serious adverse effects and sometimes lead to death. In this study, we report a case of success in the treatment of LC of a 2.5 cm lesion located in the neck region of a 22-year-old man treated with intralesional meglumine antiomoniate (IL-MA) without adverse effects and without recurrence or complications after 18 months of follow-up. The results suggest that the treatment of CL lesions with IL-MA is simple, efficient and safe. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023-02-10 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57214 10.34119/bjhrv6n1-259 |
| url |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57214 |
| identifier_str_mv |
10.34119/bjhrv6n1-259 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57214/41892 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
| publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
| dc.source.none.fl_str_mv |
Brazilian Journal of Health Review; Vol. 6 No. 1 (2023); 3323-3328 Brazilian Journal of Health Review; Vol. 6 Núm. 1 (2023); 3323-3328 Brazilian Journal of Health Review; v. 6 n. 1 (2023); 3323-3328 2595-6825 reponame:Brazilian Journal of Health Review instname:Federação das Indústrias do Estado do Paraná (FIEP) instacron:BJRH |
| instname_str |
Federação das Indústrias do Estado do Paraná (FIEP) |
| instacron_str |
BJRH |
| institution |
BJRH |
| reponame_str |
Brazilian Journal of Health Review |
| collection |
Brazilian Journal of Health Review |
| repository.name.fl_str_mv |
Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP) |
| repository.mail.fl_str_mv |
|| brazilianjhr@gmail.com |
| _version_ |
1797240026591920128 |